Blood pressure meds may lower diabetes risk

	Tweet

Two types of blood pressure-lowering medicines—so called ACE inhibitors or closely related angiotensin receptor blockers (ARBs)—can lower the risk of developing Type 2 diabetes, according to the results of a new analysis.

These two types of drugs work by regulating kidney hormones and are commonly used to treat patients with High Blood Pressure, Heart disease or heart failure.

“These two drug classes,” said Dr. Craig I. Coleman, “have been known to slow the progression of kidney disease in patients with Diabetes. However, the finding of a diabetes preventive effect is new, and will likely have an impact on the drugs doctors choose for patients with High Blood Pressure.”

Coleman, at of the University of Connecticut, Storrs, and colleagues analyzed pooled data from six trials of ACE inhibitors and five of ARBs involving more than 66,000 patients.

Both agents led to a similar reduction—by 21 percent for ACE inhibitors and 24 percent for ARBs—in new-onset diabetes, the researchers report in the journal Diabetes Care.

For patients “who might benefit similarly from any blood pressure-lowering drug, and particularly for patients who are at high risk for developing diabetes, our study demonstrates the use of either an ACE inhibitor or ARB makes sense,” Coleman commented.

“You are getting two benefits in one,” he concluded. “You are receiving a highly effective medication for your primary health problem (High Blood Pressure) and preventing the onset of a second deadly disease (diabetes).”

SOURCE: Diabetes Care, September 2005.

RELATED STORIES:
Phone contact with nurses linked with better outcomes for women with gestational diabetes   Death rate drops among Americans with diabetes -CDC   Correct treatment of common diabetic foot infections can reduce amputations   “Pre-diabetes,” diabetes rising among U.S. teens   Experimental bariatric surgery controls blood sugar in rats with diabetes   53 millions Americans might develop diabetes by 2025   New inflammation hormone link may pave way to study new drugs for type 2 diabetes   Diabetic retinopathy research could reduce screening costs   Liver fat gets a wake-up call that maintains blood sugar levels   Low testosterone levels could raise diabetes risk for men   Prosthetic lets diabetic get a foot up on life   Dealing with Diabetes, One Patient at a Time

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]